1: Yamada Y, Yokoi Y, Narita Z, Hirabayashi N. High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital. Neuropsychopharmacol Rep. 2020 Oct 10. doi: 10.1002/npr2.12140. Epub ahead of print. 2(4):acmi000105. doi: 10.1099/acmi.0.000105. 4: Gerhard T, Stroup TS, Correll CU, Setoguchi S, Strom BL, Huang C, Tan Z, Crystal S, Olfson M. Mortality risk of antipsychotic augmentation for adult depression. PLoS One. 2020 Sep 30;15(9):e0239206. doi: 10.1371/journal.pone.0239206. 5: Toro C, Shirvan L, Tifft C. HEXA Disorders. 1999 Mar 11 [updated 2020 Oct 1]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.